D D Weisenburger
Overview
Explore the profile of D D Weisenburger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
204
Citations
6650
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fetica B, Pop B, Blaga M, Fulop A, Dima D, Zdrenghea M, et al.
Blood Cancer J
. 2016 Nov;
6(11):e498.
PMID: 27834940
No abstract available.
2.
Vose J, Weisenburger D, Sanger W, Bierman P, Armitage J
Leuk Lymphoma
. 2016 Jul;
3(2):77-86.
PMID: 27457291
No abstract available.
3.
Bouska A, Zhang W, Gong Q, Iqbal J, Scuto A, Vose J, et al.
Leukemia
. 2016 Jul;
31(1):83-91.
PMID: 27389057
Follicular lymphoma (FL) is typically an indolent disease, but 30-40% of FL cases transform into an aggressive lymphoma (tFL) with a poor prognosis. To identify the genetic changes that drive...
4.
Rohr J, Guo S, Huo J, Bouska A, Lachel C, Li Y, et al.
Leukemia
. 2016 Jan;
30(5):1062-70.
PMID: 26719098
Peripheral T-cell lymphomas (PTCLs) comprise a heterogeneous group of mature T-cell neoplasms with a poor prognosis. Recently, mutations in TET2 and other epigenetic modifiers as well as RHOA have been...
5.
Morton L, Gibson T, Clarke C, Lynch C, Anderson L, Pfeiffer R, et al.
Leukemia
. 2014 Apr;
28(12):2317-23.
PMID: 24727673
Solid organ transplant recipients have elevated cancer risks, owing in part to pharmacologic immunosuppression. However, little is known about risks for hematologic malignancies of myeloid origin. We linked the US...
6.
Clarke C, Morton L, Lynch C, Pfeiffer R, Hall E, Gibson T, et al.
Br J Cancer
. 2013 Jun;
109(1):280-8.
PMID: 23756857
Background: Solid organ transplant recipients have high risk of lymphomas, including non-Hodgkin lymphoma (NHL) and Hodgkin lymphoma (HL). A gap in our understanding of post-transplant lymphomas involves the spectrum and...
7.
Iqbal J, Weisenburger D, Chowdhury A, Tsai M, Srivastava G, Greiner T, et al.
Leukemia
. 2010 Nov;
25(2):348-58.
PMID: 21052088
Natural killer (NK) cell lymphomas/leukemias are rare neoplasms with an aggressive clinical behavior. The majority of the cases belong to extranodal NK/T-cell lymphoma, nasal type (ENKTL) in the current WHO...
8.
Suzumiya J, Ohshima K, Tamura K, Karube K, Uike N, Tobinai K, et al.
Ann Oncol
. 2009 Jan;
20(4):715-21.
PMID: 19150954
Background: The International Peripheral T-cell Lymphoma Project was organized to better understand the T-cell and natural killer (NK) cell lymphomas, and our task is to present the clinicopathologic correlations and...
9.
Lenz G, Wright G, Dave S, Xiao W, Powell J, Zhao H, et al.
N Engl J Med
. 2008 Nov;
359(22):2313-23.
PMID: 19038878
Background: The addition of rituximab to combination chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP), or R-CHOP, has significantly improved the survival of patients with diffuse large-B-cell lymphoma. Whether gene-expression...
10.
Pike B, Greiner T, Wang X, Weisenburger D, Hsu Y, Renaud G, et al.
Leukemia
. 2008 Feb;
22(5):1035-43.
PMID: 18288132
In an initial epigenetic characterization of diffuse large B-cell lymphoma (DLBCL), we evaluated the DNA methylation levels of over 500 CpG islands. Twelve CpG islands (AR, CDKN1C, DLC1, DRD2, GATA4,...